✦ LIBER ✦

P91 EFFECT OF TOLL-LIKE RECEPTOR 7 AND 9 TARGETED THERAPY TO PREVENT THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA

✍ Scribed by Mohamed, F.; Al-Jehani, R.; Minogue, S.; Andreola, F.; Winstanley, A.; Olde Damink, S.; Malagó, M.; Davies, N.; Loung, T.V.; Dhillon, A.; Mookerjee, R.; Dhar, D.; Jalan, R.

Book ID: 122410543
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 81 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60254-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

293 SELECTIVE GUT DECOMTAMINATION REDUCE

293 SELECTIVE GUT DECOMTAMINATION REDUCES HEPATIC EXPRESSION OF TOLL-LIKE RECEPTOR (TLR) 4 AND DEVELOPMENT OF CIRRHOSIS BUT DOES NOT PREVENT DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC)

✍ F.E.Z. Mohamed; D. Dhar; N. Shah; N. Davies; A. Habtesion; T.V. Luong; A. Winsta 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Activation of the endotoxin/toll-like re

Activation of the endotoxin/toll-like receptor 4 pathway: The way to go from nonalcoholic steatohepatitis up to hepatocellular carcinoma

✍ Anna Alisi; Nadia Panera; Clara Balsano; Valerio Nobili 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

Toll-like receptor 9 SNPs are susceptibl

Toll-like receptor 9 SNPs are susceptible to the development and progression of membranous glomerulonephritis: 27 years follow-up in Taiwan

✍ Chen, Yng-Tay; Wei, Chang-Ching; Ng, Ka-Lok; Chen, Cheng-Hsu; Chan, Chia-Jung; C 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 262 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views